KEYNOTE-A18 Data Are ‘Practice-Changing’ for Cervical Cancer
Meeting Coverage > > IGCS Video Pearls-- Domenica Lorusso information the value of modern-day radiotherapy in this program
by Greg Laub, Director, Video, MedPage Today December 12, 2023
Incorporating checkpoint blockade with pembrolizumab (Keytruda) into basic concurrent chemoradiotherapy plus brachytherapy considerably enhanced progression-free survival in cervical cancer and revealed an early pattern towards much better general survival (OS) also, according to trial information provided at the International Gynecologic Cancer Society yearly conference.
In this MedPage Today video, lead author Domenica Lorusso, MD, PhD, of the Catholic Unive...